CVS CVS HEALTH Corp
Research report · from SEC EDGAR · close 2026-07-13
$105.90 +1.7%
$135.12B mkt cap
executive summary
CVS HEALTH Corp (CVS) is a $135.12B company. Revenue is $402.07B (+7.8% y/y) at a 0% net margin. It is profitable. Our health score is B (77/100). No major red flags on file. Held by 2 tracked funds. It funds itself; low dilution risk.
Revenue (FY)
$402.07B
+7.8% y/y
✓ No major red flags from our filing-based checks.
who's buying
Insider buys / sells
0 / 2
Cash & ST investments
$11.80B
Operating cash flow
$10.64B
Dilution shelf
active shelf
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices — every figure is real and sourced; nothing is fabricated or predicted. Filings lag 40–90 days. Educational, not investment advice. Generated 2026-07-13 by stocktools.ai.